JUNS vs MDT · rev $21.8K vs P/E 21, rev $36.36B
Jupiter Neurosciences, Inc. Common Stock (JUNS) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
JUNS currently screens at market cap $10.0M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the JUNS and MDT stock pages for the full models.
Not investment advice.